Skip to content

Drug interactions

Amiodarone + Aprepitant

Severity: Moderate

Amiodarone and Aprepitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Amiodarone is metabolized in part by CYP3A4, so aprepitant may raise amiodarone concentrations. Higher exposure could increase the risk of bradycardia, QT prolongation and arrhythmia, although the clinical effect with short aprepitant courses is not well characterized.

What this interaction means in plain words

Amiodarone and Aprepitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Amiodarone belongs to Cardiovascular; Aprepitant belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4, reducing amiodarone metabolism.

What to do

Monitor heart rate and ECG, including QTc, during aprepitant therapy. Check electrolytes and review other QT-prolonging drugs, such as some antiemetics.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amiodarone and Aprepitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Amiodarone with Aprepitant?

MediHelp rates the interaction as moderate. Amiodarone and Aprepitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Amiodarone is metabolized in part by CYP3A4, so aprepitant may raise amiodarone concentrations. Higher exposure could increase the risk of bradycardia, QT prolongation and arrhythmia, although the clinical effect with short aprepitant courses is not well characterized.

How serious is the interaction between Amiodarone and Aprepitant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and ECG, including QTc, during aprepitant therapy. Check electrolytes and review other QT-prolonging drugs, such as some antiemetics.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in